Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: a meta-analysis

Stroke

Volumn 40, Issue 6, 2009, Pages

  Kruyt, Nyika D ^a,c   Biessels, Geert Jan ^c   De Haan, Rob J ^b   Vermeulen, Marinus ^a   Rinkel, Gabriel J E ^c   Coert, Bert ^a   Roos, Yvo B W E M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Clinical outcome; Glucose; Hyperglycemia; Subarachnoid hemorrhage

Indexed keywords

GLUCOSE;

ARTICLE; BRAIN ARTERY ANEURYSM; COHORT ANALYSIS; COMORBIDITY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; BLOOD; FEMALE; MALE; META ANALYSIS; METABOLISM; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; REVIEW; TREATMENT OUTCOME;

BLOOD GLUCOSE; COHORT STUDIES; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 66849115640     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.529974     Document Type: Article

References (64)

1. 1. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007;27:369:306-318.
2. Johnston SC, Selvin S, Gress DR. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology. 1998;50: 1413-1418.
3. Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med. 2006;355:928 -939.
4. Feigin VL, Rinkel GJ, Lawes CM, Algra A, Bennett DA, van Gijn J, Anderson CS. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 2005;36:2773-2780.
5. Fergusen S, Macdonald RL. Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 2007;60:658 -667.
6. Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007;38:2315-2321.
7. Wartenberg KE, Schmidt JM, Claassen J, Wartenberg KE, Schmidt JM, Claassen J, Temes RE, Frontera JA, Ostapkovich N, Parra A, Connolly ES, Mayer SA. Impact of medical complications on outcome after sub- arachnoid hemorrhage. Crit Care Med. 2006;34:617-623.
8. Gearhart MM, Parbhoo SK. Hyperglycemia in the critically ill patient. AACN Clin Issues. 2006;17:50-55.
9. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79:992-1000.
10. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-461.
11. Bruno A, Kent TA, Coull BM, Shankar RR, Saha C, Becker KJ, Kissela BM, Williams LS. Treatment of Hyperglycemia in Ischemic Stroke (THIS): a randomized pilot trial. Stroke 2008;39:384-389.
12. Gray CS, Hildreth AJ, Sandercock PA, O'Connell JE, Johnston DE, Car- tlidge NE, Bamford JM, James OF, Alberti KG. Glucose-potassiuminsulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol. 2007;6:397-406.
13. Stroke Trials Registery Available at: www.strokecenter.org/trials/ TrialDetail.aspx?tid=681. Accessed January 6, 2008.
14. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Circulation. 2007;22:115:e478-e534.
15. Toni D, Chamorro A, Kaste M, Lees K, Wahlgren NG, Hacke W. Acute treatment of ischaemic stroke. European Stroke Initiative. Cerebrovasc Dis. 2004;17(suppl 2):30-46.
16. Nicolaysen L. Glykosurie bei meningealer Blutung. Acta MedScan. 1925; 62:392-394.
17. Charpentier C, Audibert G, Guillemin F, Civit T, Ducrocq X, Bracard S, Hepner H, Picard L, Laxenaire MC. Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage. Stroke 1999;30:1402-1408.
18. Dorhout Mees SM, van Dijk GW, Algra A, Kempink DR, Rinkel GJ. Glucose levels and outcome after subarachnoid hemorrhage. Neurology. 2003 28;61:1132-1133.
19. Frontera JA, Fernandez A, Claassen J, Schmidt M, Schumacher HC, Wartenberg K, Temes R, Parra A, Ostapkovich ND, Mayer SA. Hyper- glycemia after SAH: predictors, associated complications, and impact on outcome. Stroke 2006;37:199-203.
20. Kruyt ND, Roos YW, Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ, Biessels GJ. High mean fasting glucose levels independently predict poor outcome and delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2008;79:1382-1385.
21. Lanzino G, Kassell NF, Germanson T, Truskowski L, Alves W. Plasma glucose levels and outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1993;79:885-891.
22. Le Roux PD, Elliot JP, Newell DW, Grady MS, Winn HR. The incidence of surgical complications is similar in good and poor grade patients undergoing repair of ruptured anterior circulation aneurysms: a retrospective review of 355 patients. Neurosurgery. 1996;38:887-893.
23. Longstreth WT Jr, Nelson LM, Koepsell TD, van Belle G. Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington. Neurology. 1993;43:712-718.
24. McGirt MJ, Woodworth GF, Ali M, Than KD, Tamargo RJ, Clatterbuck RE. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2007; 107:1080 -1085.
25. Mayberg MR, Batjer HH, Dacey R, Diringer M, Haley EC, Heros RC, Sternau LL, Torner J, Adams HP Jr, Feinberg W. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994;25:2315-2328.
26. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vanden- broucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;20:370:1453-1457.
27. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Inter- observer agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607.
28. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1:480-484.
29. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;13:629 -634.
30. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;6:557-560.
31. Germanson TP, Lanzino G, Kongable GL, Torner JC, Kassell NF. Risk classification after aneurysmal subarachnoid hemorrhage. Surg Neurol. 1998;49:155-163.
32. Alberti O, Becker R, Benes L, Wallenfang T, Bertalanffy H. Initial hyperglycemia as an indicator of severity of the ictus in poor-grade patients with spontaneous subarachnoid hemorrhage. Clin Neurol Neurosurg. 2000;102:78-83.
33. Badjatia N, Topcuoglu MA, Buonanno FS, Smith EE, Nogueira RG, Rordorf GA, Carter BS, Ogilvy CS, Singhal AB. Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med. 2005;33:1603-1609.
34. Berek K, Kiechl S, Haring H-P, Kampfl A, Schmutzhard E, Gerstenbrand F. Clinical and laboratory predictors in spontaneous subarachnoid hemorrhage. Headache Quarterly. 1993;4:245-248.
35. Claassen J, Vu A, Kreiter KT, Kowalski RG, Du EY, Ostapkovich N, Fitzsimmons BF, Connolly ES, Mayer SA. Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med. 2004;32:832-838.
36. Fukui S, Katoh H, Tsuzuki N, Ishihara S, Otani N, Ooigawa H, Toyooka T, Ohnuki A, Miyazawa T, Nawashiro H, Shima K. Multivariate analysis of risk factors for QT prolongation following subarachnoid hemorrhage. Crit Care. 2003;7:R7-R12.
37. Juvela S, Siironen J, Kuhmonen J. Hyperglycemia, excess weight, and history of hypertension as risk factors for poor outcome and cerebral infarction after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2005;102:998 -1003.
38. Kitsuta Y, Suzuki N, Sugiyama M, Yamamoto I. Changes in level of consciousness and association with hyperglycemia as tool for predicting and preventing re-bleeding after spontaneous subarachnoid hemorrhage. Prehospital Disaster Med. 2006;21:190-195.
39. Lepore G, Formentano A, Boselli L, Nosari I. Clinical significance of admission hyperglycemia in critical non-diabetic patients after head injury or subarachnoid hemorrhage. Diabetes, Nutrition & Metabolism- Clinical & Experimental. 1998;3:175-178.
40. Sarrafzadeh A, Haux D, Kuchler I, Lanksch WR, Unterberg AW. Poor-grade aneurysmal subarachnoid hemorrhage: relationship of cerebral metabolism to outcome. J Neurosurg. 2004;100:400-406.
41. Sato M, Nakano M, Asari J, Watanabe K. Admission blood glucose levels and early change of neurological grade in poor-grade patients with an- eurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 2006;148:623-626.
42. Satoh A, Nakamura H, Kobayashi S, Miyata A, Matsutani M. Management of severe subarachnoid hemorrhage; significance of assessment of both neurological and systemic insults at acute stage. Acta Neurochir Suppl. 2005;94:59 -63.
43. Yoshimoto Y, Tanaka Y, Hoya K. Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke 2001;32:1989 -1993.
44. Haley EC Jr, Kassell NF, Torner JC. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg. 1993; 78:537-547.
45. Capes SE, HuntD, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;4:355:773-778.
46. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyper- glycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001;32:2426-2432.
47. Biolo G, Toigo G, Ciocchi B, Situlin R, Iscra F, Gullo A, Guarnieri G. Metabolic response to injury and sepsis: changes in protein metabolism. Nutrition. 1997;13:52S-57S.
48. Holzinger U, Kitzberger R, Fuhrmann V, Funk GC, Madl C, Ratheiser K. Correlation of calculated indices of insulin resistance (QUICKI and HOMA) with the euglycaemic hyperinsulinaemic clamp technique for evaluating insulin resistance in critically ill patients. Eur J Anaesthesiol. 2007;24:966-970.
49. Hsieh YC, Frink M, Choudhry MA, Bland KI, Chaudry IH. Metabolic modulators following trauma sepsis: sex hormones. Crit Care Med. 2007; 35:S621-S629.
50. Rusavy Z, Sramek V, Lacigova S, Novak I, Tesinsky P, Macdonald IA. Influence of insulin on glucose metabolism and energy expenditure in septic patients. Crit Care. 2004;8:R213-R220.
51. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002;19:708-723.
52. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR, Davis SM. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003;34:2208-2214.
53. Kernan WN, Viscoli CM, Inzucchi SE, Brass LM, Bravata DM, Shulman GI, McVeety JC. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke. Arch Intern Med. 2005 24;165:227-233.
54. Matz K, Keresztes K, Tatschl C, Nowotny M, Dachenhausenm A, Brainin M, Tuomilehto J. Disorders of glucose metabolism in acute stroke patients: an underrecognized problem. Diabetes Care. 2006;29:792-797.
55. Adams HP Jr, Putman SF, Kassell NF, Torner JC. Prevalence of diabetes mellitus among patients with subarachnoid hemorrhage. Arch Neurol. 1984;41:1033-1035.
56. Inagawa T. Risk factors for aneurysmal subarachnoid hemorrhage in patients in Izumo City, Japan. J Neurosurg. 2005;102:60-67.
57. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med. 2004;11:164:2005-2011.
58. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;8:345:1359 -1367.
59. Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004;30:109:1497-1502.
60. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myo- cardial infarction (DIGAMI study): effects on mortality at 1 year. JAm Coll Cardiol. 1995;26:57-65.
61. Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC, Johnson MG, Williams AR, Cutshall SM, Mundy LM, Rizza RA, McMahon MM. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 2007;20:146:233-243.
62. Cheung NW, Wong VW, McLean M. The Hyperglycemia:Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care. 2006;29:765-770.
63. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenstrom A. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myo- cardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650-661.
64. Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intra- cranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol. 2007;19:156-160.